REDHAWK ENGAGES VALERIE ALLEN PUBLIC
RELATIONS
LAFAYETTE, LA -- January
7, 2020 -- InvestorsHub NewsWire
-- RedHawk
Holdings Corp.
(OTC:
SNDD) ("RedHawk" or the "Company")
a
diversified
holding
company engaged in sales and distribution of medical devices,
branded generic pharmaceutical drugs, commercial real
estate investment and leasing, point
of entry full-body
security
systems, and
specialized financial services, announced today
the engagement
of Valerie
Allen Public Relations ("VAPR") to assist the
Company in
developing its awareness campaign
for its
Sharps and Needle Disintegration
Devices ("SANDD™"),
a proprietary line of FDA-approved and
OSHA-compliant needle incineration
medical devices used for the safe, economical and
environmentally friendly
incineration
and
disposal of hypodermic needles
Based in Los
Angeles, California, VAPR is a boutique independent full-service
public
relations firm specializing in
strategic public relations and
both social
and digital media strategies. Lead by public relations
industry
veteran
Valerie Allen, VAPR specializes in
personalities, brand awareness,
television
production,
and
event
publicity and has developed countless
national media contacts in electronic, print, radio,
trade and online
media.
Before moving to
Los Angeles, Valerie earned a Bachelor of Science degree
from Ithaca College Park School of Communications in New
York, and a Masters degree in Journalism from Temple
University's Klein College of Media and
Communication in Philadelphia. Before opening VAPR, she held
senior-level positions at public relations
powerhouses
Burson-Marsteller and Rogers & Cowan. She was also a senior
account executive at Davidson & Choy Publicity.
She has
long-standing relationships with The White House Office of National
Drug Control Policy, National Institute on Drug Abuse,
Drugfree.org, and the Entertainment
Industries Council
Prism Awards, all of which have allowed her to help
bring
awareness to
the national drug epidemic.
Commenting on the
selection of VAPR, G. Darcy Klug, RedHawk
Chairman and Interim Chief Executive Officer,
said, "We believe VAPR is an ideal selection to help
us develop
and lead our
SANDD™ product awareness
campaign.
We are
thrilled to
have VAPR agree to assist us
in the
planned
2020
launch of
our complete line
of SANDD™ products – the
SANDD
mini™, the
SANDD
HP™, the
SANDD
Pro™
and the
SANDD
Pro Portable™. We are confident that
Valerie
and
her outstanding
team will
be instrumental in helping
us
bring
the
product
awareness
and
market
excitement
that
we believe
will stimulate sales growth and the execution of our
business
model."
Valerie Allen,
Founder and Chief Executive officer of VAPR, added, "The VAPR team and I are pleased
to be working with Darcy and his team
to
help launch the
public relations awareness campaign for the full line of SANDD products. We look forward
to bringing our 20 plus years of PR expertise to assist RedHawk
in achieving its marketing goals for this exciting,
innovative and needed new product."
The
SANDD
mini™ (formerly known as The Disintegrator™) is a portable, lithium-ion
battery
operated, needle destruction device primarily for use by self-injector
diabetics in the home. In clinical settings,
the SANDD mini™ can be used by
allergist, dermatologist, cosmetologist, plastic surgeons
and other medical specialists without the need
for sharps
containers for needle disposal. The
SANDD
mini™ provides diabetics with the safe and environmentally friendly
disposal of needles following their use in a home
setting and
is an effective alternative to hazardous waste needle disposal utilizing
sharps
containers. The SANDD mini™ is the only FDA-approved portable,
battery-operated needle destruction device that
eliminates the use of sharps containers for disposal in
both
clinical and home settings.
Other models
include
the
SANDD-HP™, which operates with both AC and/or DC
power and
is designed specifically for
healthcare professionals for use in both a
clinical/office or portable setting. The major electronic
components
of the SANDD-HP™ are expected to
be
manufactured
in the United States.
Lastly, the
SANDD Pro™
is capable of incinerating hypodermic needles 18-gauge
and higher, up to 8 inches in length. Additionally,
SANDD Pro™
technology features a portable,
rechargeable, lithium-ion
battery operated unit.
RedHawk
believes that this portable unit (the
"SANDD Pro™ - Portable") will incinerate as many as 300
needles on
a single charge, ranging in gauges as thick as
21 gauge and lengths up to 8". RedHawk expects that
the
SANDD Pro™
- Portable will be ideal for field use by first responders, retirement-home health care nurses,
veterinarians,
home use
injectors and the like. The
SANDD Pro™
is both FDA approved and OSHA compliant.
The complete line
of SANDD™ products is expected
to
soon
be available for
virtually all home and
commercial
applications
including hospitals, first responders, as well as a full range of clinics
and
primary care physicians, dentists, veterinarians, retirement and
non-acute healthcare facilities. The
SANDD
mini™ and the SANDD-HP™ are currently being sold to the general
public and
to various Independent School Districts in the State of
Texas. The
Company has started installing
SANDD
mini™ and SANDD-HP™ demonstration units
into various
Independent
School Districts located in the States of Louisiana and Mississippi. Additionally, RedHawk
has agreed to
begin providing both its
SANDD-HP™ and its
SANDD
Pro™ units
to certain California and Louisiana
law enforcement
agencies for
use by their patrol
divisions
and
their
evidence
rooms.
# # #
About RedHawk Holdings
Corp.
RedHawk Holdings Corp., formerly
Independence Energy Corp., is a
diversified holding company which, through
its subsidiaries, is engaged in sales
and distribution of medical devices,
sales of branded generic pharmaceutical
drugs, commercial real
estate investment and leasing,
sales of point of entry full-body
security systems, and specialized
financial services. Through its
medical products business unit,
the Company sells the Sharps and Needle
Destruction Device (SANDD™),
WoundClot Surgical - Advanced
Bleeding Control, and
the Carotid Artery
Digital Non-Contact
Thermometer. Through our United Kingdom based
subsidiary, we manufacture and market
branded generic
pharmaceuticals. RedHawk Energy holds the
exclusive U.S. manufacturing and
distribution rights for the
Centri Controlled Entry System, a
unique, closed cabinet, nominal dose
transmission full-body x-ray
scanner.
Cautionary Statement Regarding
Forward-Looking
Statements
This release may contain forward-looking statements.
Forward-looking statements are
all statements other than
statements of historical fact.
Statements contained in this release that are not
historical facts may be deemed to be
forward-looking statements. The words
"anticipate," "may," "can," "plans," "believes,"
"estimates," "expects,"
"projects," "targets," "intends,"
"likely," "will," "should," "to be,"
"potential" and any similar expressions are
intended to identify those assertions as
forward-looking statements.
Investors are cautioned that forward-looking
statements are inherently
uncertain. Actual
performance and results may
differ materially from that projected or
suggested herein due to certain risks and
uncertainties. In evaluating
forward-looking statements, you should consider the various
factors which may cause actual
results to differ materially
from any forward-looking
statements including those listed in the
"Risk Factors" section of our latest 10-K
report. Further, the Company
may make changes to its business plans that could or will
affect its results. Investors are
cautioned that the Company
will undertake no obligation to
update any forward-looking
statements.
Company
Contact:
G. Darcy
Klug, Chairman,
CEO and CFO
(337)
269-5933
darcy.klug@redhawkholdingscorp.com
Investor
Relations:
Stephanie
Prince, Managing Director
PCG Advisory
(646) 762-4518
sprince@pcgadvisory.com
Media
Contact:
Valerie
Allen
Valerie Allen
Public Relations
(310)
382-7800
valerie@valerieallenpr.com
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Apr 2024 to May 2024
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From May 2023 to May 2024